SHARPIN and prostate cancer: SHARPIN expression is associated with poor prognosis in some other types of cancer; for example, SHARPIN-mediated activation of NF-κΒ signaling and the downstream targets survivin and livin promotes the progression and metastasis of prostate cancer [23].